BDSX Q1 2020 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$138M

Q1 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$5M-17.4% YoY

Gross Profit

$4M69.0% margin

Operating Income

-$8M-165.3% margin

Net Income

-$10M-190.4% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-38.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$0

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$6M	-17.4%
Gross Profit	$4M	$5M	-26.8%
Operating Income	-$8M	-$6M	-41.8%
Net Income	-$10M	-$7M	-33.0%